Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jerome Martin Babau
OpenAlex ID:
A5099012745
TOPOLOGY: A phase II study to evaluate the efficacy and toxicities of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer.
2024
·
Luc Cabel
, Delphine Loirat
, et al.
·
Journal of Clinical Oncology
·
1
PDF
TUC-TOC phase II trial (NCT05955170): Tucatinib in combination with oral etoposide (VP16) and trastuzumab in patients with metastatic HER2-positive breast cancer (HER2+ mBC).
2026
·
Diana Bello Roufai
, Alexia Savignoni
, et al.
·
Journal of Clinical Oncology
PDF
NoLEEta: No chemotherapy in intermediate-risk HR+ HER2− early breast cancer treated with ribociclib in the adjuvant setting—A non-inferiority phase III trial.
2026
·
Francois Clement Bidard
, Thomas Bachelot
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
3
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
